ARCT
Arcturus Therapeutics Holdings Inc

5,453
Mkt Cap
$202.58M
Volume
1.36M
52W High
$24.17
52W Low
$5.85
PE Ratio
-2.89
ARCT Fundamentals
Price
$7.13
Prev Close
$6.83
Open
$6.85
50D MA
$12.70
Beta
1.79
Avg. Volume
986,719.74
EPS (Annual)
-$3.00
P/B
0.86
Rev/Employee
$786,301.14
Loading...
Loading...
News
all
press releases
ARCT Stock Plunges 59% in Three Months: Here's What You Need to Know
Arcturus Therapeutics' stock slides 59%, primarily due to mixed interim results from the phase II study of its investigational inhaled cystic fibrosis therapy, ARCT-032.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Arcturus Therapeutics (NASDAQ:ARCT) Shares Pass Below 200 Day Moving Average - Should You Sell?
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Passes Below 200-Day Moving Average - Here's Why...
MarketBeat·10d ago
News Placeholder
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve research firms that are currently covering the stock, MarketBeat...
MarketBeat·20d ago
News Placeholder
Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to "Hold"
Wall Street Zen upgraded shares of Arcturus Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·20d ago
News Placeholder
Arcturus Therapeutics (NASDAQ:ARCT) Price Target Lowered to $9.00 at Citigroup
Citigroup dropped their price target on shares of Arcturus Therapeutics from $12.00 to $9.00 and set a "neutral" rating on the stock in a research note on Thursday...
MarketBeat·22d ago
News Placeholder
Research Analysts Offer Predictions for ARCT FY2025 Earnings
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) - Research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Arcturus Therapeutics in a...
MarketBeat·22d ago
News Placeholder
William Blair Has Optimistic Outlook of ARCT FY2025 Earnings
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) - Stock analysts at William Blair lifted their FY2025 earnings estimates for shares of Arcturus Therapeutics in a research report...
MarketBeat·22d ago
News Placeholder
Arcturus Therapeutics (NASDAQ:ARCT) Given New $72.00 Price Target at Piper Sandler
Piper Sandler decreased their target price on shares of Arcturus Therapeutics from $140.00 to $72.00 and set an "overweight" rating on the stock in a report on Tuesday...
MarketBeat·24d ago
News Placeholder
HC Wainwright Lowers Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $9.00
HC Wainwright decreased their price objective on Arcturus Therapeutics from $12.00 to $9.00 and set a "neutral" rating for the company in a report on Tuesday...
MarketBeat·24d ago
News Placeholder
Arcturus Therapeutics (NASDAQ:ARCT) Issues Quarterly Earnings Results, Beats Estimates By $0.60 EPS
Arcturus Therapeutics (NASDAQ:ARCT - Get Free Report) announced its quarterly earnings results on Monday. The biotechnology company reported ($0.49) earnings per share (EPS) for the quarter, beating...
MarketBeat·25d ago

Latest ARCT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.